Cargando…
An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn’s Disease
The diagnostic accuracy of point-of-care (PoC) applications may be compromised in individuals with additional inflammatory conditions. This cross-sectional study examined the performance of a commercial oral rinse active matrix metalloproteinase-8 (aMMP-8) PoC immunotest in individuals with (n = 47)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175303/ https://www.ncbi.nlm.nih.gov/pubmed/32143418 http://dx.doi.org/10.3390/biom10030395 |
_version_ | 1783524806391496704 |
---|---|
author | Rautava, Jaana Gürsoy, Ulvi K. Kullström, Adrian Könönen, Eija Sorsa, Timo Tervahartiala, Taina Gürsoy, Mervi |
author_facet | Rautava, Jaana Gürsoy, Ulvi K. Kullström, Adrian Könönen, Eija Sorsa, Timo Tervahartiala, Taina Gürsoy, Mervi |
author_sort | Rautava, Jaana |
collection | PubMed |
description | The diagnostic accuracy of point-of-care (PoC) applications may be compromised in individuals with additional inflammatory conditions. This cross-sectional study examined the performance of a commercial oral rinse active matrix metalloproteinase-8 (aMMP-8) PoC immunotest in individuals with (n = 47) and without Crohn’s disease (CD) (n = 41). Oral rinse collected from the participants was analyzed by the PoC immunotest. Molecular forms and fragments of salivary MMP-8 were detected by western immunoblotting. The sensitivity of the immunotest for periodontitis was 60.0% in the CD group and 90.0% in the control group. The respective specificity was 75.0% and 80.0%. In both groups, clinical diagnosis of periodontitis exhibited a significant association with the immunotest results, however, the odds ratio (OR) was more than ten-fold in controls (OR 54.3, 95% CI: 3.1–953, p = 0.006) in comparison to CD patients (OR 5.2, 95% CI: 1.3–21.6, p = 0.022). According to Western immunoblot results, the immunotest MMP-8 positivity was not related to elevated levels of molecular forms and fragments of MMP-8 in the CD group, as in the control group. The diagnostic accuracy of the aMMP-8 PoC oral rinse immunotest is reduced in CD patients, which may be related to lower levels or undetectable complexes. |
format | Online Article Text |
id | pubmed-7175303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71753032020-04-28 An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn’s Disease Rautava, Jaana Gürsoy, Ulvi K. Kullström, Adrian Könönen, Eija Sorsa, Timo Tervahartiala, Taina Gürsoy, Mervi Biomolecules Article The diagnostic accuracy of point-of-care (PoC) applications may be compromised in individuals with additional inflammatory conditions. This cross-sectional study examined the performance of a commercial oral rinse active matrix metalloproteinase-8 (aMMP-8) PoC immunotest in individuals with (n = 47) and without Crohn’s disease (CD) (n = 41). Oral rinse collected from the participants was analyzed by the PoC immunotest. Molecular forms and fragments of salivary MMP-8 were detected by western immunoblotting. The sensitivity of the immunotest for periodontitis was 60.0% in the CD group and 90.0% in the control group. The respective specificity was 75.0% and 80.0%. In both groups, clinical diagnosis of periodontitis exhibited a significant association with the immunotest results, however, the odds ratio (OR) was more than ten-fold in controls (OR 54.3, 95% CI: 3.1–953, p = 0.006) in comparison to CD patients (OR 5.2, 95% CI: 1.3–21.6, p = 0.022). According to Western immunoblot results, the immunotest MMP-8 positivity was not related to elevated levels of molecular forms and fragments of MMP-8 in the CD group, as in the control group. The diagnostic accuracy of the aMMP-8 PoC oral rinse immunotest is reduced in CD patients, which may be related to lower levels or undetectable complexes. MDPI 2020-03-04 /pmc/articles/PMC7175303/ /pubmed/32143418 http://dx.doi.org/10.3390/biom10030395 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rautava, Jaana Gürsoy, Ulvi K. Kullström, Adrian Könönen, Eija Sorsa, Timo Tervahartiala, Taina Gürsoy, Mervi An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn’s Disease |
title | An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn’s Disease |
title_full | An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn’s Disease |
title_fullStr | An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn’s Disease |
title_full_unstemmed | An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn’s Disease |
title_short | An Oral Rinse Active Matrix Metalloproteinase-8 Point-of-Care Immunotest May Be Less Accurate in Patients with Crohn’s Disease |
title_sort | oral rinse active matrix metalloproteinase-8 point-of-care immunotest may be less accurate in patients with crohn’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175303/ https://www.ncbi.nlm.nih.gov/pubmed/32143418 http://dx.doi.org/10.3390/biom10030395 |
work_keys_str_mv | AT rautavajaana anoralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT gursoyulvik anoralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT kullstromadrian anoralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT kononeneija anoralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT sorsatimo anoralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT tervahartialataina anoralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT gursoymervi anoralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT rautavajaana oralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT gursoyulvik oralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT kullstromadrian oralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT kononeneija oralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT sorsatimo oralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT tervahartialataina oralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease AT gursoymervi oralrinseactivematrixmetalloproteinase8pointofcareimmunotestmaybelessaccurateinpatientswithcrohnsdisease |